Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lanir

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|April 29, 1998
Coexistence of acquired protein S and protein C deficiency and the Arg506Gln mutation in factor Va in a child with severe thromboembolic diseaseI Shavit, B Brenner, N Lanir, et al.
American Heart Journal|May 20, 1998
Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditionsD Varon, I Lashevski, B Brenner, et al.
British Journal of Haematology|June 1, 1997
Activated protein C resistance can be associated with recurrent fetal lossB Brenner, H Mandel, N Lanir, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 4, 2000
Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy lossJ S Younis, B Brenner, G Ohel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 31, 2000
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutationJ S Younis, G Ohel, B Brenner, et al.
Blood|August 1, 1996
Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosisB Brenner, A Zivelin, N Lanir, et al.
American Journal of Ophthalmology|February 1, 2000
Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutationD Dori, I Beiran, Y Gelfand, et al.
Journal of Neuroimmunology|February 1, 1996
Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseasesA Miller, N Lanir, S Shapiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokinesS Youssef, G Wildbaum, G Maor, et al.
The American Journal of Pathology|January 1, 1993
Fibroblast migration in fibrin gel matricesL F Brown, N Lanir, J McDonagh, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Acta Paediatrica (Oslo, Norway : 1992)|April 29, 1998
Coexistence of acquired protein S and protein C deficiency and the Arg506Gln mutation in factor Va in a child with severe thromboembolic diseaseI Shavit, B Brenner, N Lanir, et al.
American Heart Journal|May 20, 1998
Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditionsD Varon, I Lashevski, B Brenner, et al.
British Journal of Haematology|June 1, 1997
Activated protein C resistance can be associated with recurrent fetal lossB Brenner, H Mandel, N Lanir, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|March 4, 2000
Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy lossJ S Younis, B Brenner, G Ohel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 31, 2000
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutationJ S Younis, G Ohel, B Brenner, et al.
Blood|August 1, 1996
Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosisB Brenner, A Zivelin, N Lanir, et al.
American Journal of Ophthalmology|February 1, 2000
Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutationD Dori, I Beiran, Y Gelfand, et al.
Journal of Neuroimmunology|February 1, 1996
Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseasesA Miller, N Lanir, S Shapiro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokinesS Youssef, G Wildbaum, G Maor, et al.
The American Journal of Pathology|January 1, 1993
Fibroblast migration in fibrin gel matricesL F Brown, N Lanir, J McDonagh, et al.
Pageof 5